Embed presentation
Download to read offline


This study investigates the potential of TGF-β2 modified CD34+ hematopoietic stem cells to repair retinal vascular damage in diabetic patients. It demonstrates that TGF-β2 blockade enhances the migration and repair functions of these cells, potentially reversing the damage caused by diabetic retinopathy. The findings suggest a novel therapeutic approach to treat vision loss due to ischemic conditions in diabetic individuals.
